A detailed history of Ars Wealth Advisors Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ars Wealth Advisors Group, LLC holds 6,368 shares of ABBV stock, worth $1.15 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,368
Previous 6,107 4.27%
Holding current value
$1.15 Million
Previous $1.05 Million 20.06%
% of portfolio
0.16%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $42,762 - $52,025
261 Added 4.27%
6,368 $1.26 Million
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $87,920 - $102,671
568 Added 10.25%
6,107 $1.05 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $30,685 - $34,963
-192 Reduced 3.35%
5,539 $1.01 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $497,974 - $560,836
-3,619 Reduced 38.71%
5,731 $888,000
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $510,180 - $590,608
3,819 Added 69.05%
9,350 $1.39 Million
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $194,259 - $241,743
1,466 Added 36.06%
5,531 $745,000
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $3,759 - $4,330
-26 Reduced 0.64%
4,065 $647,000
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $13,139 - $15,757
-95 Reduced 2.27%
4,091 $661,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $561,803 - $644,350
4,186 New
4,186 $562,000
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $561,668 - $644,197
-4,185 Closed
0 $562,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $28,624 - $36,391
-208 Reduced 4.73%
4,185 $641,000
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $42,761 - $53,055
-324 Reduced 6.87%
4,393 $712,000
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $2,685 - $3,398
25 Added 0.53%
4,717 $639,000
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $499,228 - $566,699
4,692 New
4,692 $506,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ars Wealth Advisors Group, LLC Portfolio

Follow Ars Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.